Med-tech’s feverish investment outpaces biopharma

In every type of financing, from IPOs and follow-on public offerings to private placements and venture capital rounds, the med-tech industry produced more money and completed more financings in 2018 than the prior year, reflecting the same significant jump in activity seen with its biopharma counterpart. What is different, however, is that med tech experienced […]

Women have their say as all-female panel talks biopharma investment, technology trends

This article is part of an ongoing series from Clarivate Analytics celebrating women in STEM with profiles of female scientists, inventors, researchers, and corporate leaders featured in BioWorld, Derwent, Web of Science, and Publons. See more articles in this series, or follow our online campaign using #WomenAtClarivate. One of the hottest tickets in town during […]

Cancer, neurology, immune therapies drive continued robust pace of biopharma financings

2017 was recorded as the second highest financings year for the biopharmaceutical industry. High enthusiasm was demonstrated among investors who funneled about two-thirds of the money through public offerings. BioPharma Financings Reports, 15 separate analyses compiled by BioWorld and Clarivate Analytics focused on key therapeutic markets, found that in addition to cancer companies, firms working […]